Last Updated: 18/06/2024

Development and mechanism study of fully human new structural antibodies targeting Plasmodium falciparum PfRH5

Objectives

This project aims at the development and study of the mechanism of fully human new structural antibodies targeting Plasmodium falciparum PfRH5.

Principal Institution

Fudan University, China

Principal Investigators / Focal Persons

Yanling Wu

Themes

Basic Science

Date

Jan 2020 — Dec 2022

Total Project Funding

$31,944

Funding Details
National Natural Science Foundation of China (NSFC), China

Grant ID: 81902108
CNY 210,000
Country / Project Site(s)

China

SHARE

Related Resources

Report of an expert consultation on the clinical development plan for a multistage malaria vaccine targeting the circumsporozoite (CS) and blood stage (BS) antigens
Report of an expert consultation on the clinical development plan for a multistage malaria vaccine targeting the circumsporozoite (CS) and blood stage (BS) antigens
Monoclonal antibodies for malaria prevention: Preferred product characteristics and clinical development considerations
Monoclonal antibodies for malaria prevention: Preferred product characteristics and clinical development considerations
ASTMH 2018, Camila H Coelho: “The first human monoclonal antibody against the sexual stage Plasmodium falciparum antigen Pfs230”
ASTMH 2018, Camila H Coelho: “The first human monoclonal antibody against the sexual stage Plasmodium falciparum antigen Pfs230”

Related Projects

Jan 2024 —
Dec 2028
Development of novel antimalarial therapeutics targeting Plasmodium falciparum lipid-binding proteins
May 2022 —
Apr 2023
Determinants of transmission-blocking properties of antibodies targeting the 6C domain of Pfs48/45 of the Plasmodium falciparum parasite
Jan 2019 —
Dec 2021
Isolation of broadly neutralizing human antibodies against Plasmodium falciparum
SHARE